Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-02

Clinical Trial Update: Stereotactic Radiotherapy Combined With Chemotherapy or Not for Treatment of Oligometastases in HNSCC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating stereotactic radiotherapy with or without chemotherapy for oligometastatic head and neck squamous cell carcinoma; currently ac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Groupe Oncologie Radiotherapie Tete et Cou | Conditions: Head and Neck Squamous Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING